Aker BioMarine

What Aker BioMarine does

Aker BioMarine ASA, founded in 2006 and listed on the Oslo Stock Exchange under ticker AKBM, is a Norwegian biotech innovator and the world's leading supplier of Antarctic krill-derived ingredients. The company operates a vertically integrated value chain from proprietary Eco-Harvesting vessels in the Southern Ocean, through a Montevideo logistics hub, to a Flexitech-based production facility in Houston, Texas, and a protein facility in Ski, Norway. Its technology base includes phospholipid extraction (PL+ platform), LPC-bound EPA/DHA delivery (Lysoveta, 40 patents in 16 countries), unmanned surface vehicles (Mariner USV), and a Cognite Data Fusion digital platform that has driven 56% unit cost reductions and 73% less downtime.

Aker BioMarine monetizes its krill and algae ingredients across four business segments: Human Health Ingredients (Superba Krill Oil, Lysoveta, FloraMarine, PL+ — B2B sales to nutraceutical manufacturers; $26.0M in Q1 2025, +16% YoY), Consumer Health Products (Kori Krill consumer brand, Lang Pharma Nutrition; $27.1M in Q1 2025, +4% YoY), Animal Feed (QRILL Aqua and QRILL Pet, partially divested in July 2024), and Emerging Business (Understory protein, AION circular economy, CaPre therapeutic, KRBNX biostimulants; $2.1M in Q1 2025). Revenue is generated primarily through B2B ingredient contracts, with distribution partnerships (Barentz in Europe, G.C. Chemie Pharmie in India, Function in China) and licensing/royalties (Trofi Nutritional for Lysoveta medical foods targeting Alzheimer's, male infertility, and gestational diabetes). Q1 2025 company revenue was USD 50.8M (+5% YoY) with adjusted EBITDA of USD 9.0M (+59%); 91% of turnover is from exports across more than 40 nationalities.

Name

Aker BioMarine

Legal name

Aker BioMarine ASA

Website

https://akerbiomarine.com

Company type

Public

Founded year

2006

Operating status

Operating

Headcount range

251–500 employees

Short description

Aker BioMarine ASA is the world's leading supplier of Antarctic krill-derived ingredients, producing phospholipid omega-3 oils, proteins, and algae DHA for nutraceutical, pharmaceutical, aquaculture, and consumer health customers globally from its vertically integrated Antarctic-to-Houston supply chain.

Ownership category

akta.pro rank

Product category

Marine-derived nutraceutical ingredients

NAICS

Aquaculture (1125)

SIC

Prepared Fresh Or Frozen Fish & Seafoods (2092)

akta.pro primary industry

Sustainable & Alternative-Protein Aquafeed (Insect, Algae, Single-Cell, Byproduct-Based) (AFADADAM)

akta.pro secondary industries

Aquaculture Feed & Nutrition (farm-level feed programs) (AFAEAAAL), Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF)

Keywords

• Krill oil ingredients
• Marine omega-3
• Krill harvesting
• Aquaculture feed
• Krill protein

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Human Health Ingredients: Sale of krill-derived ingredients (Superba Krill Oil, Lysoveta, FloraMarine, PL+) to nutraceutical and supplement manufacturers. Q1 2025 revenue of USD 26.0 million with 16% YoY growth. Nine consecutive quarters of revenue growth.
2. Consumer Health Products: Sale of consumer-facing products including Kori Krill brand in US retail market, and Lang Pharma Nutrition products. Q1 2025 revenue of USD 27.1 million with 4% YoY growth.
3. Animal Feed Ingredients: QRILL Aqua (aquaculture) and QRILL Pet (animal feed) product sales. Stable revenue with favorable developments in fish meal and fish oil markets.
4. Emerging Business: Understory protein brand and other emerging ventures. Revenue of USD 2.1 million in Q1 2025, focused on reaching cash break-even.
5. Licensing and Royalties: Licensing of Lysoveta intellectual property to Trofi Nutritional Inc. for medical foods targeting Alzheimer's disease, male infertility, and gestational diabetes. Royalty payments on sales.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels6 records

Core offering

Aker BioMarine harvests Antarctic krill using its proprietary Eco-Harvesting technology and converts it into krill oil, krill meal, and krill protein ingredients supplied to dietary supplement manufacturers, aquaculture feed companies, and pet food producers. The company also offers algae-derived DHA (Revervia) and a phospholipid-bound omega-3 ingredient (Lysoveta), markets a consumer-facing krill oil brand (Kori Krill Oil), and pursues emerging circular-economy applications such as AION and krill protein (Understory).

Product overview

Aker BioMarine offers a diversified portfolio of marine-based ingredients and consumer products organized across four business segments: Human Health Ingredients (Superba Krill Oil, Revervia algae DHA, LYSOVETA brain health, PL+ delivery technology, FloraMarine), Consumer Health Products (Kori Krill brand), Emerging Business (Understory protein, AION circular economy, CaPre therapeutic candidate, KRBNX agriculture biostimulants), and Animal Nutrition (QRILL Aqua for aquaculture, QRILL Pet for pet food). The company operates a fully transparent value chain from Antarctic krill harvesting through Montevideo logistics hub and Houston production facility to global customers in nutraceuticals, pharmaceuticals, aquaculture, and animal feed industries.

Differentiator

Problem solved

Functional benefit

Brands

• Superba Krill Oil: Natural source of essential omega-3s, phospholipids, choline and astaxanthin for human health
• Revervia
• Lysoveta
• PL+ Technology
• Understory
• AION
• Kori
• CaPre
• KRBNX
• FloraMarine
• QRILL Aqua
• QRILL Pet

Products and services

• Superba Krill Oil
• QRILL Aqua
• QRILL Pet
• Lysoveta
• Kori Krill Oil
• Revervia
• Understory
• AION

Quantifiable outcome

• 16% YoY revenue growth in Human Health Ingredients (Q1 2025)
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

19 partnerships are on record, tiered core and minor.

• ENGIEcoreStrategic or Co-development Partner · 17 June 202624/7 renewable energy agreement enabling approximately 90% of electricity consumption at Houston facility to be matched hourly with local renewable generation from the Impact Solar Project in Lamar County, Texas. Supports sustainability goals and reduces Scope 2 emissions as part of 2030 carbon intensity reduction strategy. Facilitated by advisor Priority Power.
• Priority PowerminorImplementation/ SI/ Consulting Partner · 17 June 2026Served as advisory partner in structuring the renewable energy transaction with ENGIE, helping align energy solutions with Aker BioMarine's sustainability priorities.
• Sustainable Markets Initiative (SMI)coreStrategic or Co-development Partner · 11 March 2026Ocean Stewardship Initiative (OSI) developed in partnership with SMI, Aker BioMarine, Aker QRILL Company, and Marine Stewardship Council. Initial focus on Marine Protected Area covering 70% of Antarctic Peninsula. John Kerry appointed as Champion.
• Marine Stewardship CouncilcoreStrategic or Co-development Partner · 11 March 2026Partnership for Ocean Stewardship Initiative focused on marine protection and science-based fisheries management. Supporting proposed Marine Protected Area covering 70% of Antarctic Peninsula.
• Academic Research InstitutionscoreStrategic or Co-development Partner · 16 January 2026Partnership with academia on neurodegenerative disease prevention research.
• G.C. Chemie Pharmie Pvt. Ltd.coreChannel Partner/ Reseller/ Distributor · 12 January 2026Strategic distribution partnership to expand distribution of krill oil and algae-derived DHA ingredients across the Indian market. Part of India market expansion ahead of Vitafoods India 2026.
• Aker QRILL CompanycoreStrategic or Co-development Partner · 31 October 2025CCAMLR 2025 collaboration supporting Antarctic Peninsula MPA proposal. Joint participation at Clinton Global Initiative to promote Antarctic protection. Scale up circular partnership with AION.
• AIONcoreStrategic or Co-development Partner · 15 October 2025Circular partnership scaled up to reduce packaging waste. Agreement to transform over 3,000 pallets from used product bags into fully circular system, reducing plastic footprint and carbon emissions.
• Clinton Global InitiativeminorStrategic or Co-development Partner · 22 September 2025Aker BioMarine and Aker QRILL Company participating to promote Antarctic MPA proposal at CGI Annual Meeting 2025.
• KGK Science Inc.coreStrategic or Co-development Partner · 30 April 2025Clinical research organization engaged for Lysoveta clinical trial. Randomized, placebo-controlled trial enrolling 138 healthy adults aged 50-75 with mild memory complaints. Study to assess cognitive function, mood, omega-3 status, and BDNF levels over 112 days.
• Norwegian Board AssociationminorGTM or Marketing Partner · 19 November 2024Sponsorship and partnership to advance sports and inclusion. Aker BioMarine became main sponsor alongside VI Foundation.
• Barentz International B.V.coreChannel Partner/ Reseller/ Distributor · 14 October 2024Distribution agreement with global specialty ingredients solution provider for new marine ingredients in Europe.
• FunctioncoreChannel Partner/ Reseller/ Distributor · 12 April 2024Strategic partnership declaration with largest customer of Superba Krill oil in China. Includes intention for Function to license Kori brand in China and be first customer of Understory protein. Pursuing long-term strategic partnership for krill-based products.
• University of GlasgowcoreStrategic or Co-development Partner · 24 February 2024Research partnership to investigate health benefits of krill oil and krill protein. Study led by university showed beneficial effects on skeletal muscle function and size.
• CognitecoreTechnology or Integration · 22 May 2023Digital transformation partnership using Cognite Data Fusion platform. 3 million data points contextualized, 56% unit cost reduction, 73% downtime reduction, 2x output improvement in Houston facility and Antarctic vessels.
• Microsoft NorwaycoreTechnology or Integration · 2 May 2023MoU signed to pursue joint innovation and co-sell opportunities within digital traceability of circular plastic products. Microsoft to help scale AION Loop platform globally using cloud and AI services.
• CSIROcoreStrategic or Co-development Partner · 6 September 2022Collaboration with Australia's national science agency on krill oil research. Joint winners of 2022 Nutra Ingredients Asia Award for osteoarthritis study.
• Trofi Nutritional Inc.coreOEM/ Whitelabel/ Licensing Partner · 1 September 2022Licensing agreement for Lysoveta intellectual property and supply. Trofi will invest in clinical trials targeting Alzheimer's disease, male infertility, and gestational diabetes, with royalty payments on sales. First medical food planned for 2024.
• Antarctic Wildlife Research Fund (AWR)coreStrategic or Co-development Partner · 30 June 2022USD 1 million commitment over 5 years to support AWR's work on Antarctic ecosystem research. Fund established by Aker BioMarine, ASOC, and WWF-Norway in 2015. Has financed 20 research projects and 15 host institutions.

Scale indicators28 records

Recent moves11 records

Expansion highlights9 records

Direct peers

• KD Pharma Group: KD Pharma is a major manufacturer of omega-3 fatty acid concentrates and other lipid-based APIs and nutraceuticals. It competes with Aker BioMarine in the omega-3 ingredient space, though KD Pharma focuses more on fish oil concentrates versus Aker BioMarine's krill-derived phospholipid focus.
• Golden Omega: Golden Omega is a Chilean-based krill oil producer and direct competitor to Aker BioMarine, supplying krill oil ingredients for human nutrition supplements. They compete for the same B2B nutraceutical customers and are pursuing similar phospholipid-bound omega-3 positioning.
• BioMar: BioMar is one of the world's largest aquaculture feed manufacturers and a direct customer/competitor to Aker BioMarine's QRILL Aqua business. Both supply high-performance feeds for salmon, shrimp, and other farmed seafood, with BioMar representing a major channel for krill meal inclusion.
• Rimfrost: Rimfrost is a direct competitor in krill oil harvesting and ingredient production, sourcing from Antarctic waters. Like Aker BioMarine, it supplies krill-derived omega-3 phospholipid ingredients to nutraceutical manufacturers globally, making it the closest head-to-head competitor in the core krill oil market.

Broad incumbents

• DSM-Firmenich: DSM-Firmenich is a global science-based company in nutrition, health, and beauty, with a major presence in omega-3 ingredients (including the Veramaris JV), animal nutrition, and food ingredients. It is a broad incumbent that competes across multiple Aker BioMarine segments including aquaculture feed and supplement ingredients.
• Skretting (Nutreco): Skretting is the global aquaculture feed business of Nutreco and a dominant incumbent in fish and shrimp feed markets. It competes with Aker BioMarine in the aquaculture feed value chain and is a key potential customer for QRILL Aqua krill meal as an ingredient.
• Cargill: Cargill is one of the world's largest agricultural and food ingredient companies with significant presence in animal nutrition (including Cargill Aqua Nutrition) and plant-based omega-3 (via its partnership with BASF on algal DHA). It represents a broad incumbent competitor across Aker BioMarine's human health and animal feed segments.
• ADM Animal Nutrition: ADM is a global leader in human and animal nutrition with a major animal feed business. It is a broad incumbent that competes with Aker BioMarine's QRILL Pet and QRILL Aqua products in the animal nutrition segment, while also providing competing plant-based protein ingredients to the broader market.

Emerging players

• Checkerspot: Checkerspot is a biotechnology company producing novel oils and ingredients from microalgae, with applications in nutrition, personal care, and food. It represents an emerging competitor in the algae-based omega-3 and specialty lipid space, challenging Aker BioMarine's premium positioning with novel production methods.
• Veramaris: Veramaris is a DSM/Evonik joint venture producing algae-based EPA and DHA for aquaculture and human nutrition. It represents the main alternative to krill-derived omega-3 and competes with Aker BioMarine in both supplement and aquaculture feed markets with a vegan-friendly positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/aker-biomarine-antarctic
• Xx.com/AkerBioMarine
• Facebookfacebook.com/akerbiomarine

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aker BioMarine